TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-02-26 for TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[39088763] Siemens technical operations has confirmed that the trig_c assay reagent lots 348297 and 359932 are not linear to the instructions for use (ifu) claim of 550 mg/dl (62. 15 mmol/l). Siemens diagnostics is investigating this issue.
Patient Sequence No: 1, Text Type: N, H10


[39088764] The customer has observed a drop in linearity for the triglycerides_2 concentrated assay when using reagent lot 348297 on the advia chemistry 2400 instrument. The linearity study was carried out on three different advia chemistry 2400 instruments. In addition a linearity study was also carried out on the new lot of triglyceride _2 reagent 359932. A comparison of data was provided between the two different reagent lots used for the linearity study. There were no reports of patient intervention or adverse health consequences due to the trig_c assay not meeting linearity claims.
Patient Sequence No: 1, Text Type: D, B5


[41946304] The initial mdr 2432235-2016-00101 was filed on 2/26/2016. Additional information (2/29/2016): siemens healthcare diagnostics has confirmed the trig_c reagent kit lots 348297 and 359932( smn 10697575) used on the advia 1200, 1650, 1800, 2400, and xpt chemistry systems does not meet instructions for use (ifu) linearity claim at the upper limit of the assay range as it approaches end of shelf life. Internal testing demonstrated that a patient bias (-12% to -15%) may be seen at concentration levels between 450 to 550mg/dl. Linearity is reduced by approximately 31% at higher triglyceride concentrations up to 1200mg/dl (13. 56mmol/l). An urgent field safety notice (ufsn) chc16-03. A. Ous was sent to ous customers and a urgent medical device recall (umdr) chc16-03. A. Us was sent to us customers in march of 2016. The ufsn and umdr state that customers are to discontinue use and discard reagent kit lots 348297 and 359932.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2016-00101
MDR Report Key5462626
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-02-26
Date of Report2016-02-08
Date of Event2016-02-04
Date Mfgr Received2016-02-29
Date Added to Maude2016-02-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactAARTI AZIZ
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242683
Manufacturer G1RANDOX LABORATORIES LTD. (REG# 8020890)
Manufacturer Street55 DIAMON ROAD CRUMLIN
Manufacturer CityCO. ANTRIM, BT294QY
Manufacturer CountryUK
Manufacturer Postal CodeBT29 4QY
Single Use3
Previous Use Code3
Removal Correction Number2432235-03/09/2016-001-R
Event Type3
Type of Report3

Device Details

Brand NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Generic NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Product CodeCDT
Date Received2016-02-26
Model NumberTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Catalog Number10697575
Lot Number348297, 359932
Device Availability*
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-02-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.